(Q44659325)

5 December 2017

Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder (English)

1 reference

transitional cell carcinoma

5 December 2017

1 reference

Gohji K

1

1 reference

5 December 2017

Nomi M

2

1 reference

5 December 2017

Okamoto M

3

1 reference

5 December 2017

Takenaka A

4

1 reference

5 December 2017

Hara I

5

1 reference

5 December 2017

Okada H

6

1 reference

5 December 2017

Arakawa S

7

1 reference

5 December 2017

Fujii A

8

1 reference

5 December 2017

Kamidono S

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

5 December 2017

1 reference

5 December 2017

53

1 reference

5 December 2017

308-313

1 reference

5 December 2017

2

1 reference

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

The significance of lamina propria invasion on the prognosis of patients with bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Analysis by step sectioning of early invasive bladder cancer with special reference to G3.pT1 disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

The Management of Superficial Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Bladder carcinoma as a systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

The correlation of T1 bladder tumour history with prognosis and follow-up requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

The pT1 G3 bladder tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900480-4

7 January 2021

10.1016/S0090-4295(98)00480-4

Identifiers

DOI

1 reference

5 December 2017

1 reference